# RAG Query Log

Automated exports from genomic RAG notebooks.

---

## Query: BRCA1 hereditary breast cancer pathogenic

**Run:** archived (migrated from `combined_rag.ipynb`) · **Search:** combined (ClinVar + UniProt) · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`)

### Summary

The query "BRCA1 hereditary breast cancer pathogenic" indicates that there is a pathogenic variant in the BRCA1 gene on chromosome 17. The full ClinVar record for this variant shows that it is a single nucleotide polymorphism (SNP) with the change C -> T at position 241. This variant has been classified as pathogenic based on the review status and phenotype list provided.

---

## Query: BRCA1 hereditary breast cancer pathogenic

**Run:** archived (migrated from `combined_rag.ipynb`) · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The BRCA1 gene has several pathogenic variants associated with hereditary breast cancer. Notable variants include:

1. **VariationID: 54565** - NM_007294.4(BRCA1):c.241C>T (p.Gln81Ter), which is classified as pathogenic and linked to hereditary breast ovarian cancer syndrome.
2. **VariationID: 55580** - NM_007294.4(BRCA1):c.5444G>A (p.Trp1815Ter), also classified as pathogenic and associated with familial breast and ovarian cancer.
3. **VariationID: 54957** - NM_007294.4(BRCA1):c.3661G>T (p.Glu1221Ter), which is similarly classified as pathogenic and related to hereditary breast ovarian cancer syndrome.

All these variants have been reviewed by expert panels and are significant in increasing the risk of breast and ovarian cancers.

---

## Query: CFTR cystic fibrosis

**Run:** archived (migrated from `combined_rag.ipynb`) · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Cystic fibrosis is associated with mutations in the CFTR gene, which encodes the cystic fibrosis transmembrane conductance regulator protein. Two specific pathogenic variants in the CFTR gene are noted: NM_000492.4(CFTR):c.1475C>T (p.Ser492Phe) (ClinVar VariationID: 7155) and NM_000492.4(CFTR):c.933C>G (p.Phe311Leu) (ClinVar VariationID: 7153). Both variants have been reviewed by expert panels and are linked to cystic fibrosis and related disorders.

The CFTR protein, known as the cystic fibrosis transmembrane conductance regulator (Entry Name: CFTR_HUMAN), functions as an epithelial ion channel that regulates ion and water transport across cell membranes. It plays a crucial role in maintaining fluid homeostasis in various tissues, including the respiratory system, where its dysfunction leads to the symptoms of cystic fibrosis.

---

## Query: breast cancer hereditary pathogenic

**Run:** archived (migrated from `clinvar_rag.ipynb`) · **Search:** clinvar · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`, `SYSTEM_PROMPT`)

### Summary

The query "breast cancer hereditary pathogenic" was answered with two results from ClinVar, one for the gene BRCA1 and another for the gene BRCA2. Both variants identified pathogenic mutations in these genes associated with hereditary breast cancer.

---

## Query: breast cancer hereditary pathogenic

**Run:** archived (migrated from `clinvar_rag.ipynb`) · **Search:** clinvar · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`, `SYSTEM_PROMPT_1`, 1st run)

### Summary

The query "breast cancer hereditary pathogenic" was answered with two variants in the ClinVar database:

1. **NM_007294.4(BRCA1)**: A pathogenic variant at position 241 on chromosome 17 that changes the amino acid from valine to glutamine at codon 81. This variant has been reported as causing hereditary breast ovarian cancer syndrome.

2. **NM_007294.4(BRCA1)**: A pathogenic variant at position 5251 on chromosome 17 that changes the amino acid from arginine to cysteine at codon 1751. This variant has been reported as causing hereditary breast ovarian cancer syndrome.

Both variants have been reviewed by an expert panel and are considered pathogenic based on the available evidence.

---

## Query: breast cancer hereditary pathogenic

**Run:** archived (migrated from `clinvar_rag.ipynb`) · **Search:** clinvar · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`, `SYSTEM_PROMPT_1`, 2nd run)

### Summary

The user's query "breast cancer hereditary" was answered with two variants in the ClinVar database:

1. **Variation ID: 54604** - This variant is associated with **Benign** genetic changes in the **BRCA1** gene on chromosome 17. The clinical significance is that it may be associated with **Hereditary breast ovarian cancer syndrome**.

2. **Variation ID: 41803** - This variant is also associated with **Benign** genetic changes in the **BRCA1** gene on chromosome 17. It has been reported as being associated with **Hereditary breast ovarian cancer syndrome**.

Both variants have been reviewed by an expert panel and are listed under the **Hereditary breast ovarian cancer syndrome** category.

---

## Query: mismatch repair mechanism

**Run:** archived (migrated from `uniprot_rag.ipynb`) · **Search:** uniprot · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`, `SYSTEM_PROMPT`)

### Summary

The MSH3 protein interacts with several genes, including DUC1, DUG, and MSH2. Specifically, it forms a heterodimer with MSH2 to bind to DNA mismatches, initiating DNA repair. The interaction involves the regions 31-122, where there is a disordered region due to the presence of natural variants.

---

## Query: mismatch repair mechanism

**Run:** archived (migrated from `uniprot_rag.ipynb`) · **Search:** uniprot · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`, `SYSTEM_PROMPT_1`, 1st run)

### Summary

The query "mismatch repair mechanism" was answered using the following evidence:

UniProt entry: P52701
Accession: P52701
Gene: MSH6
Description: Component of the post-replicative DNA mismatch repair system (MMR). Heterodimerizes with MSH2 to form MutS alpha, which binds to DNA mismatches thereby initiating DNA repair.

This entry describes the MSH6 protein, which plays a key role in the post-replicative DNA mismatch repair system. Specifically, it mentions that MSH6 heterodimerizes with MSH2 to form MutS alpha, which binds to DNA mismatches to initiate DNA repair.

---

## Query: mismatch repair mechanism

**Run:** archived (migrated from `uniprot_rag.ipynb`) · **Search:** uniprot · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`, `SYSTEM_PROMPT_1`, 2nd run)

### Summary

The query "mismatch repair mechanism" was answered using the following UniProt protein searches:

UniProt ID: P52701
Protein: MSH6_HUMAN
Accession: P52701
Gene: MSH6
Function: DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)

This indicates that MSH6 is involved in mismatch repair mechanisms, particularly DNA mismatch repair proteins like Msh6.

---

## Query: CFTR cystic fibrosis

**Run:** 2026-06-13 08:46:49 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Cystic fibrosis is associated with mutations in the CFTR gene, which encodes the cystic fibrosis transmembrane conductance regulator protein. Two specific pathogenic variants in the CFTR gene are noted: NM_000492.4(CFTR):c.1475C>T (p.Ser492Phe) (ClinVar VariationID: 7155) and NM_000492.4(CFTR):c.933C>G (p.Phe311Leu) (ClinVar VariationID: 7153). Both variants have been reviewed by expert panels and are linked to cystic fibrosis and related disorders.

The CFTR protein, known as the cystic fibrosis transmembrane conductance regulator (Entry Name: CFTR_HUMAN), functions as an epithelial ion channel that regulates ion and water transport across cell membranes. It plays a crucial role in maintaining fluid homeostasis in various tissues, including the respiratory and digestive systems. Defects in this protein lead to the symptoms of cystic fibrosis, which include chronic respiratory issues and pancreatic insufficiency.

---

## Query: mismatch repair mechanism

**Run:** 2026-06-13 08:49:44 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The mismatch repair mechanism is primarily facilitated by proteins involved in the DNA mismatch repair (MMR) system. Key proteins include:

1. **MSH6 (Entry Name: MSH6_HUMAN)**: This protein forms a heterodimer with MSH2 to create MutS alpha, which recognizes and binds to DNA mismatches. It initiates the repair process by bending the DNA and forming a complex with MutL alpha to direct downstream repair events. MSH6 is crucial for recognizing single base mismatches and small insertion-deletion loops.

2. **MSH2 (Entry Name: MSH2_HUMAN)**: MSH2 also forms heterodimers, including MutS alpha with MSH6 and MutS beta with MSH3. It plays a similar role in recognizing mismatches and initiating repair, bending the DNA, and forming complexes that facilitate the repair process.

3. **MSH3 (Entry Name: MSH3_HUMAN)**: This protein forms MutS beta with MSH2 and is responsible for recognizing larger insertion-deletion loops. It also participates in the downstream repair processes.

These proteins are essential for maintaining genomic stability and preventing mutations that can lead to diseases such as Lynch syndrome and various cancers.

---

## Query: CpG island

**Run:** 2026-06-13 08:55:25 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The term "CpG island" is associated with the protein HAP40, which is also known as the 40-kDa huntingtin-associated protein. According to the UniProt record (Entry Name: HAP40_HUMAN, Accession: P23610), HAP40 is involved in vesicular trafficking of early endosomes and is up-regulated in brain tissue from patients with Huntington's disease. It is noted as a "CpG island protein," indicating its potential relevance in genomic regions rich in cytosine and guanine dinucleotides.

No specific variant evidence from ClinVar was provided in the retrieved records related to the query about CpG islands.

---

## Query: TDG

**Run:** 2026-06-13 08:56:43 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query "TDG" likely refers to the protein Thyroglobulin (Tg), which is encoded by the gene TG. According to UniProt (Entry Name: THYG_HUMAN, Accession: P01266), Thyroglobulin is involved in the production of thyroid hormones, specifically thyroxine (T4) and triiodothyronine (T3). It is secreted into the thyroid follicle lumen and plays a crucial role in thyroid hormone synthesis.

In terms of disease involvement, variants in the TG gene are associated with conditions such as Thyroid dyshormonogenesis 3 (TDH3) and Autoimmune thyroid disease 3 (AITD3). For example, ClinVar records indicate that certain variants (e.g., VariationID for TDH3) can lead to significant thyroid dysfunction and related symptoms.

Overall, TDG appears to be linked to the TG gene and its protein product, Thyroglobulin, which is essential for thyroid hormone production and is implicated in specific thyroid-related disorders.

---

## Query: thymine DNA glycosylase

**Run:** 2026-06-13 08:58:04 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The protein associated with thymine DNA glycosylase activity is the Endonuclease III-like protein 1, also known as hNTH1, which is encoded by the gene NTHL1 (UniProt Entry Name: NTH_HUMAN, Accession: P78549). This protein functions as a bifunctional DNA N-glycosylase and AP lyase, playing a crucial role in the base excision repair pathway by recognizing and repairing oxidative damage to DNA, particularly pyrimidines.

In terms of genetic variants, ClinVar records indicate that variants affecting the NTHL1 gene can lead to familial adenomatous polyposis 3 (ClinVar VariationID: not specified). This condition is characterized by the development of multiple colorectal adenomatous polyps, which can progress to colorectal cancer. 

Overall, the evidence highlights the importance of the NTHL1 gene and its protein product in DNA repair and its association with disease.

---

## Query: rb1

**Run:** 2026-06-13 08:59:46 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query "rb1" refers to the RB1 gene, which encodes the Retinoblastoma-associated protein (Entry Name: RB_HUMAN, Accession: P06400). This protein is a tumor suppressor that plays a crucial role in regulating the cell cycle, particularly the transition from G1 to S phase. It binds to transcription regulators of the E2F family to prevent the transcription of genes necessary for cell cycle progression.

Variants in the RB1 gene are associated with several diseases, including retinoblastoma (a childhood cancer), bladder cancer, and osteogenic sarcoma. For example, ClinVar records indicate various natural variants, such as VARIANT 72 (E -> Q) and VARIANT 137 (E -> D), which have been studied in relation to these conditions.

In summary, the RB1 gene is significant for its role in cancer suppression, and its variants can lead to serious health conditions.

---

## Query: E -> Q

**Run:** 2026-06-13 09:01:18 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query refers to a variant change from E (glutamic acid) to Q (glutamine). However, the provided evidence does not specify any variant with this exact change. 

From the UniProt records, we have information about the protein QRICH1 (Entry Name: QRIC1_HUMAN), which is involved in various cellular functions and associated with Ververi-Brady syndrome 1 (VERBRAS1). There are several natural variants listed for QRICH1, but none specifically mention an E to Q change.

In summary, there is no evidence available for the E to Q variant change in the provided records.

---

## Query: bcl-2

**Run:** 2026-06-13 09:02:27 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query "bcl-2" refers to the BCL2 gene, which encodes the protein known as the Apoptosis regulator Bcl-2. According to the UniProt record (Entry Name: BCL2_HUMAN, Accession: P10415), this protein is involved in suppressing apoptosis (cell death) in various cell types and plays a role in regulating mitochondrial membrane permeability. It is located in the outer membrane of the mitochondrion, as well as in the nucleus and endoplasmic reticulum.

In terms of genetic variants, the ClinVar database indicates several variants associated with BCL2, including VariationID VAR_000827 (T -> S) and VAR_014716 (A -> T), which have been linked to non-Hodgkin lymphomas. These variants may affect the function of the Bcl-2 protein and are relevant in the context of certain diseases. 

Overall, BCL2 is significant in cancer biology, particularly in lymphomas, due to its role in regulating cell survival.

---

## Query: bax, bak, bim

**Run:** 2026-06-13 09:04:10 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query mentions "bax," "bak," and "bim," but the retrieved evidence does not provide specific information about these proteins or their variants. 

From the UniProt records, we have information on three different proteins: 

1. **SON_HUMAN (Protein SON)** - This protein is involved in RNA splicing and is associated with ZTTK syndrome (MIM:617140). It has several natural variants, including VARIANT 1637 (T -> S) and VARIANT 1843 (S -> Y), which are noted to have uncertain significance.

2. **SIL1_HUMAN (Nucleotide exchange factor SIL1)** - This protein is essential for protein folding in the endoplasmic reticulum and is linked to Marinesco-Sjoegren syndrome (MSS) (MIM:248800). A natural variant noted is VARIANT 80 (Q -> R).

3. **BTK_HUMAN (Tyrosine-protein kinase BTK)** - This protein is crucial for B lymphocyte development and is associated with X-linked agammaglobulinemia (XLA) (MIM:300755). It has numerous variants, including VARIANT 11 (L -> P) and VARIANT 12 (K -> R), which are linked to the disease.

Unfortunately, there is no direct information regarding "bax," "bak," or "bim" in the provided records.

---

## Query: pro-apoptotic proteins

**Run:** 2026-06-13 09:05:17 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Pro-apoptotic proteins are involved in the process of programmed cell death, known as apoptosis. Two key pro-apoptotic proteins are Caspase-8 and Caspase-10.

1. **Caspase-8 (CASP8_HUMAN, Q14790)**: This protein plays a crucial role in initiating apoptosis by activating other caspases that execute cell death. It is involved in the extrinsic apoptosis pathway, mediating cell death signals from receptors like FAS and TNFRSF1A. Caspase-8 also has functions in necroptosis and pyroptosis, and its deficiency can lead to autoimmune lymphoproliferative syndrome (ALPS) characterized by defective apoptosis and immunodeficiency.

2. **Caspase-10 (CASPA_HUMAN, Q92851)**: Similar to Caspase-8, Caspase-10 is part of the caspase activation cascade that executes apoptosis. It is recruited to death receptors in a FADD-dependent manner and can activate other effector caspases. Variants in the CASP10 gene are associated with autoimmune lymphoproliferative syndrome 2A (ALPS2A) and various cancers, including gastric cancer.

Both proteins are essential for regulating apoptosis and maintaining immune system balance.

---

## Query: enabling replicative immortality

**Run:** 2026-06-13 09:06:54 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

To enable replicative immortality, the protein "timeless homolog" (hTIM), encoded by the TIMELESS gene (UniProt Entry Name: TIM_HUMAN), plays a crucial role in DNA replication and maintenance of genome stability. It stabilizes replication forks during DNA replication and is involved in DNA repair processes, which are essential for cell survival after DNA damage. This protein also interacts with other factors to regulate DNA synthesis and repair, contributing to the overall maintenance of cellular integrity.

There are no specific variants from ClinVar mentioned in the provided evidence that directly relate to enabling replicative immortality. However, the function of the TIM protein in DNA replication and repair suggests its importance in processes that could contribute to replicative immortality.

---

## Query: tert promoter

**Run:** 2026-06-13 09:08:54 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query about the "tert promoter" relates to the TERT gene, which encodes the protein Telomerase reverse transcriptase (UniProt Entry Name: TERT_HUMAN, Accession: O14746). This protein is essential for the replication of chromosome ends (telomeres) and is active in progenitor and cancer cells, but typically inactive in normal somatic cells. Variants in the TERT gene are associated with several diseases, including aplastic anemia and various forms of cancer.

However, the provided evidence does not include specific information about the TERT promoter itself or any variants directly affecting it. Therefore, while the TERT gene and its protein are well-documented, details about the promoter region are not available in the retrieved records.

---

## Query: nahr

**Run:** 2026-06-13 09:11:16 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query "nahr" appears to relate to the Aryl hydrocarbon receptor (AhR), which is encoded by the AHR gene. According to UniProt (Entry Name: AHR_HUMAN, Accession: P35869), the Aryl hydrocarbon receptor is a ligand-activated transcription factor involved in various biological processes, including development, immunity, and cancer. It plays a role in sensing environmental compounds and regulating gene expression.

There is no specific variant evidence from ClinVar provided in the retrieved records for the AHR gene. Therefore, no details about specific genetic variants or their clinical significance are available.

---

## Query: non-allelic homologous recombination

**Run:** 2026-06-13 09:12:05 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Non-allelic homologous recombination is a process that involves proteins important for DNA repair and meiotic recombination. 

From the UniProt records, the protein **Meiotic recombination protein REC114** (Entry Name: RE114_HUMAN) is required for the formation of DNA double-strand breaks during meiotic recombination, which is essential for spermatogenesis and oogenesis. It interacts with other proteins to facilitate this process.

Another relevant protein is the **Homologous recombination OB-fold protein** (Entry Name: HROB_HUMAN), which is involved in homologous recombination by recruiting helicase complexes to DNA damage sites, promoting DNA repair synthesis.

These proteins play critical roles in ensuring proper genetic recombination and repair mechanisms, which are vital for fertility and the maintenance of genomic integrity.

---

## Query: di george syndrome

**Run:** 2026-06-13 09:13:34 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

DiGeorge syndrome is not directly mentioned in the provided evidence. However, the records include information about proteins and variants that may be relevant to neurodevelopmental disorders. 

1. **Protein Evidence**: 
   - **GNB5_HUMAN (Guanine nucleotide-binding protein subunit beta-5)**: This protein is involved in neuronal signaling and is associated with Lodder-Merla syndrome, which includes features like impaired intellectual development and cardiac arrhythmia (UniProt Entry: O14775).
   - **GBB2_HUMAN (Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2)**: This protein is linked to neurodevelopmental disorders characterized by hypotonia and developmental delays (UniProt Entry: P62879).
   - **GDIA_HUMAN (Rab GDP dissociation inhibitor alpha)**: This protein is associated with intellectual developmental disorders and is involved in regulating Rab proteins (UniProt Entry: P31150).

2. **Variant Evidence**: 
   - Variants in the GNB5 gene are linked to Lodder-Merla syndrome (ClinVar VariationID not provided).
   - Variants in the GNB2 gene are associated with neurodevelopmental disorders (ClinVar VariationID not provided).
   - Variants in the GDI1 gene are linked to intellectual developmental disorder, X-linked 41 (ClinVar VariationID not provided).

While these proteins and variants are related to developmental and intellectual disorders, specific information about DiGeorge syndrome is not included in the provided records.

---

## Query: cellular apoptosis

**Run:** 2026-06-13 09:15:02 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Cellular apoptosis, or programmed cell death, is a crucial biological process regulated by various proteins. One key protein involved in this process is Nucleolar protein 3 (NOL3), which acts as an apoptosis repressor. It inhibits both extrinsic and intrinsic apoptotic pathways by interacting with proteins like FAS, FADD, and CASP8, thereby blocking the assembly of death-inducing signaling complexes and limiting the activation of caspases (ClinVar: NOL3, VariationID not specified). 

Another important protein is Caspase-8 (CASP8), which serves as an initiator protease in the extrinsic apoptosis pathway. It activates downstream effector caspases that lead to cell death and is also involved in regulating necroptosis and pyroptosis (UniProt: CASP8_HUMAN, Caspase-8). Additionally, Caspase-2 (CASP2) plays a role in apoptosis regulation by forming complexes that activate apoptosis in response to stress (UniProt: CASP2_HUMAN, Caspase-2).

Overall, these proteins are essential for controlling apoptosis and maintaining cellular homeostasis.

---

## Query: methylation aging

**Run:** 2026-06-27 08:51:50 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Methylation aging refers to the changes in DNA methylation patterns that occur as an individual ages. Two key proteins involved in DNA methylation are DNMT1 and DNMT3A. 

1. **DNMT1 (Entry Name: DNMT1_HUMAN)** is a DNA methyltransferase that maintains methylation patterns during DNA replication and is essential for epigenetic inheritance. It preferentially methylates hemimethylated DNA and is involved in transcriptional repression by binding to histones. Variants in the DNMT1 gene can lead to hereditary sensory neuropathy and cerebellar ataxia.

2. **DNMT3A (Entry Name: DNM3A_HUMAN)** is another DNA methyltransferase that is crucial for establishing DNA methylation patterns during development. It is involved in de novo methylation and can also modify non-CpG sites. Variants in the DNMT3A gene are associated with several conditions, including Tatton-Brown-Rahman syndrome and acute myelogenous leukemia.

Both proteins play significant roles in the regulation of gene expression through methylation, which is a key aspect of aging and cellular function.

---

## Query: How does methylation affect aging?

**Run:** 2026-06-27 08:57:41 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Methylation plays a significant role in aging through its impact on gene expression and epigenetic regulation. The protein DNA (cytosine-5)-methyltransferase 1 (Dnmt1), which is encoded by the DNMT1 gene (UniProt Entry Name: DNMT1_HUMAN), is responsible for maintaining DNA methylation patterns, particularly during DNA replication. This process is crucial for epigenetic inheritance and gene silencing, which can influence aging and age-related diseases.

Additionally, DNA (cytosine-5)-methyltransferase 3A (Dnmt3a), encoded by the DNMT3A gene (UniProt Entry Name: DNM3A_HUMAN), is essential for establishing DNA methylation patterns during development. It is involved in genome-wide de novo methylation, which is important for regulating gene expression throughout life.

Overall, the activity of these methyltransferases and the resulting DNA methylation patterns are key factors in the aging process, affecting how genes are expressed as organisms age.

---

## Query: How does methylation affect aging?

**Run:** 2026-06-27 08:59:21 UTC · **Search:** clinvar · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`)

### Summary

Methylation affects aging through its role in DNA methylation patterns, which can lead to changes in gene expression and potentially contribute to age-related diseases such as cancer and hereditary disorders like Lynch syndrome.

---

## Query: What is extrachromosomal segregation?

**Run:** 2026-06-27 08:59:49 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The provided evidence does not contain a definition or explanation of "extrachromosomal segregation." Therefore, I cannot provide a summary regarding this concept based on the available records.

---

## Query: extrachromosomal segregation

**Run:** 2026-06-27 09:02:42 UTC · **Search:** combined (ClinVar + UniProt) · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query about "extrachromosomal segregation" does not have direct evidence in the provided records. However, related information can be found in the context of chromosome behavior during cell division.

From the UniProt records, the protein BUB1B (Entry Name: BUB1B_HUMAN) is essential for the mitotic checkpoint, which ensures that chromosomes are properly attached to the spindle before separation. Defects in the BUB1B gene are associated with premature chromatid separation (PCS), which involves separate and splayed chromatids during metaphase. This condition can lead to tumor formation and is noted in the context of chromosomal stability.

Additionally, the protein ESCO2 (Entry Name: ESCO2_HUMAN) is involved in establishing sister chromatid cohesion, which is crucial for proper chromosome segregation during cell division. Variants in the ESCO2 gene are linked to disorders characterized by premature centromere separation, which may relate to the concept of extrachromosomal segregation.

In summary, while there is no specific mention of "extrachromosomal segregation," the proteins BUB1B and ESCO2 are involved in processes that ensure proper chromosome behavior during cell division, with implications for chromosomal stability and segregation.

---

## Query: Which pathogenic variants are associated with genetic methylation?

**Run:** 2026-06-27 09:03:40 UTC · **Search:** clinvar · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`)

### Summary

The pathogenic variant identified in the ClinVar database for the gene MT-TH is likely pathogenic, as it results in the substitution of one amino acid at position 12147 (m.12147G>A) in the mtDNA sequence. This variant is part of the MERRF/MELAS overlap syndrome, which includes MELAS syndrome, Mitochondrial Disease, and other related conditions. The variant has been reported to cause MERRF/MELAS syndrome, MELAS syndrome, Mitochondrial disease, MT-TH-related disorders, primary Mitochondrial Disorders, and other diseases.

---

## Query: Which variants can reverse methylation?

**Run:** 2026-06-27 09:08:09 UTC · **Search:** clinvar · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`)

### Summary

The ClinVar database provides information on variants that can reverse methylation. The first result shows a variant at position 11C>T in the GAMT gene, which has been reported to be benign. The second result indicates that a variant at position 194T>C (p.Leu65Pro) in the same gene is pathogenic and associated with a deficiency of guanidinoacetate methyltransferase. The third result mentions a variant at position 460-31G>A in the same gene, also being pathogenic and associated with a deficiency of guanidinoacetate methyltransferase.

---

## Query: Which epigenetic changes are associated with aging?

**Run:** 2026-06-27 09:11:32 UTC · **Search:** clinvar · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`)

### Summary

The Epigenetic change c.4G>A (p.Ala2Thr) in the gene NM_000251.3(MSH2) has been identified as likely benign. This variant is associated with Lynch syndrome and hereditary cancer predisposition syndromes, including Lynch syndrome 1, hereditary nonpolyposis colorectal neoplasms, and breast and/or ovarian cancer. The variant also affects MSH2 protein stability, which may contribute to its role in cancer development.

---

## Query: Microbial community

**Run:** 2026-06-27 09:14:52 UTC · **Search:** clinvar · **Summarizer:** local (`Qwen/Qwen2.5-0.5B-Instruct`)

### Summary

The query "Microbial community" was answered with two results from ClinVar, one for the gene MSH6 and another for the gene MSH6. Both variants have been identified as likely pathogenic mutations. The first variant has a Clinical Significance of Likely Pathogenic, while the second variant has a Clinical Significance of Pathogenic.

---

## Query: Microbial community

**Run:** 2026-06-27 09:17:02 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The provided ClinVar records focus on variations in the MSH6 gene, which are associated with Lynch syndrome and other hereditary cancer-predisposing conditions. 

1. **VariationID 89391** (NM_000179.3(MSH6):c.3439-2A>G) is classified as likely pathogenic and is linked to several cancers, including endometrial and colorectal cancers.
   
2. **VariationID 218057** (NM_000179.3(MSH6):c.3172G>C) is also likely pathogenic and is associated with Lynch syndrome and colorectal cancer.

3. **VariationID 89534** (NM_000179.3(MSH6):c.467C>G) is classified as pathogenic and is related to Lynch syndrome and various cancers, including endometrial carcinoma.

There is no information provided about microbial communities in these records.

---

## Query: Which epigenetic changes are associated with aging?

**Run:** 2026-06-27 09:17:47 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The provided ClinVar records do not contain information about epigenetic changes associated with aging. They focus on variations in the MSH2 gene, which are related to various cancer syndromes, but do not address aging or epigenetic changes. Therefore, I cannot provide an answer to your query based on the available data.

---

## Query: Which pathogenic variants are associated with genetic methylation?

**Run:** 2026-06-27 09:18:29 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Two likely pathogenic variants associated with genetic methylation are:

1. **VariationID: 9610**, Name: **NC_012920.1(MT-TH):m.12147G>A** in the gene **MT-TH**. This variant is linked to conditions such as MERRF/MELAS overlap syndrome and mitochondrial diseases.

2. **VariationID: 91377**, Name: **NM_000535.7(PMS2):c.903G>T (p.Lys301Asn)** in the gene **PMS2**. This variant is associated with Lynch syndrome and other hereditary cancer-predisposing syndromes.

3. **VariationID: 9245**, Name: **NM_000535.7(PMS2):c.137G>T (p.Ser46Ile)** in the gene **PMS2**. This variant is also related to Lynch syndrome and various cancer disorders.

These variants are noted for their potential impact on genetic methylation processes.

---

## Query: methylation

**Run:** 2026-06-27 09:19:22 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The retrieved ClinVar records do not provide specific information about methylation. However, they include details about three pathogenic variations related to the MSH6 and MSH2 genes, which are associated with Lynch syndrome and other hereditary cancer-predisposing syndromes. The variations are:

1. VariationID: 89312, Name: NM_000179.3(MSH6):c.2731C>T (p.Arg911Ter)
2. VariationID: 90677, Name: NM_000251.3(MSH2):c.1477C>T (p.Gln493Ter)
3. VariationID: 90881, Name: NM_000251.3(MSH2):c.2087C>T (p.Pro696Leu)

If you need more specific information about methylation, it is not available in the provided records.

---

## Query: breast cancer hereditary pathogenic

**Run:** 2026-06-27 09:22:10 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

There are several pathogenic variations associated with hereditary breast cancer. 

1. The variation NM_007294.4(BRCA1):c.241C>T (p.Gln81Ter) with VariationID 54565 is linked to hereditary breast and ovarian cancer syndrome and is classified as pathogenic.

2. Another variation, NM_007294.4(BRCA1):c.5251C>T (p.Arg1751Ter) with VariationID 55480, is also classified as pathogenic and is associated with similar hereditary cancer syndromes.

3. Additionally, the variation NM_000059.4(BRCA2):c.8167G>C (p.Asp2723His) with VariationID 52515 is pathogenic and linked to hereditary breast and ovarian cancer syndrome as well.

All these variations indicate a hereditary risk for breast cancer.

---

## Query: Which variants are associated with angiogenic switch?

**Run:** 2026-06-27 09:23:28 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The variants associated with the angiogenic switch based on the provided ClinVar records are:

1. **VariationID: 977129** - NM_000419.5(ITGA2B):c.2444A>G (p.Tyr815Cys), which is likely pathogenic and is linked to Glanzmann thrombasthenia and gastric cancer.

2. **VariationID: 560377** - NM_000152.5(GAA):c.4G>T (p.Gly2Ter), which is also likely pathogenic and associated with elevated circulating creatine kinase concentration, glycogen storage disease type II, and melanoma.

The second variant, **VariationID: 282138** - NM_000152.5(GAA):c.258C>A (p.Pro86=), is likely benign and does not indicate a strong association with the angiogenic switch. 

No additional information on other variants related to the angiogenic switch is available in the provided records.

---

## Query: Which variants are related to APOBEC deamination?

**Run:** 2026-06-27 09:25:39 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The provided ClinVar records do not specifically mention any variants related to APOBEC deamination. The variants listed are all associated with the MYOC gene and are primarily linked to open-angle glaucoma. The variants include:

1. VariationID: 875083, Name: NM_000261.2(MYOC):c.801T>C (p.Tyr267=) - Likely benign.
2. VariationID: 30205, Name: NM_000261.2(MYOC):c.1430T>A (p.Ile477Asn) - Likely pathogenic.
3. VariationID: 7951, Name: NM_000261.2(MYOC):c.1440C>A (p.Asn480Lys) - Pathogenic.

No information regarding their relation to APOBEC deamination is available in the records.

---

## Query: APOBEC deamination?

**Run:** 2026-06-27 09:26:21 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The retrieved ClinVar records do not provide specific information about APOBEC deamination. However, they include three variations in the APC gene that are classified as likely pathogenic, associated with conditions like familial adenomatous polyposis and hereditary cancer-predisposing syndromes. The variations are:

1. VariationID: 1050028, Name: NM_000038.6(APC):c.423-8A>G
2. VariationID: 433614, Name: NM_000038.6(APC):c.835-7T>G
3. VariationID: 411555, Name: NM_000038.6(APC):c.1626+3A>G

If you need more specific information about APOBEC deamination, it is not available in the provided records.

---

## Query: Which variants are associated with hormonal dysfunction?

**Run:** 2026-06-27 09:28:15 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The variants associated with hormonal dysfunction are not explicitly mentioned in the provided ClinVar records. However, the following variants are noted:

1. **VariationID: 102539** - NM_000277.3(PAH):c.1159T>C (p.Tyr387His) is likely pathogenic and is associated with phenylketonuria and malignant breast tumors.

2. **VariationID: 102726** - NM_000277.3(PAH):c.529G>A (p.Val177Met) is pathogenic and linked to phenylketonuria, hyperphenylalaninemia, and PAH-related disorders.

3. **VariationID: 102784** - NM_000277.3(PAH):c.688G>A (p.Val230Ile) is likely pathogenic and also associated with phenylketonuria and PAH-related disorders.

None of these records specifically indicate a direct association with hormonal dysfunction.

---

## Query: Which variants cause melanoma?

**Run:** 2026-06-27 09:29:41 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The variant NM_000546.6(TP53):c.659A>G (p.Tyr220Cys) with VariationID 127819 is classified as pathogenic and is associated with several cancer conditions, including melanoma as part of the broader category of hereditary cancer-predisposing syndromes. Another variant, NM_000546.6(TP53):c.743G>A (p.Arg248Gln) with VariationID 12356, is also pathogenic and linked to various cancers, including melanoma. 

The variant NM_005026.5(PIK3CD):c.371-3C>T with VariationID 474030 is classified as benign and is associated with uveal melanoma, but it is not considered pathogenic. 

In summary, the TP53 variants (127819 and 12356) are linked to melanoma, while the PIK3CD variant (474030) is benign.

---

## Query: Which variants cause benign tumors?

**Run:** 2026-06-27 09:30:42 UTC · **Search:** clinvar · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The following variants are classified as likely benign and are associated with DICER1-related tumor predisposition:

1. VariationID: 412157, Name: NM_177438.3(DICER1):c.128C>T (p.Thr43Met)
2. VariationID: 412179, Name: NM_177438.3(DICER1):c.4412C>T (p.Pro1471Leu)
3. VariationID: 315107, Name: NM_177438.3(DICER1):c.3269+14G>A

These variants may be linked to benign tumors, but specific details about the tumors are not provided in the records.

---

## Query: APOBEC deamination

**Run:** 2026-06-27 10:08:08 UTC · **Search:** uniprot · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

The query about APOBEC deamination does not have relevant information in the provided UniProt records. The entries focus on proteins such as the Adenomatous polyposis coli protein (APC_HUMAN) and its related proteins, which are involved in tumor suppression and microtubule stabilization, but do not mention APOBEC or its deamination activity. Therefore, I cannot provide specific details regarding APOBEC deamination based on the given records.

---

## Query: IGF-1

**Run:** 2026-06-27 10:17:44 UTC · **Search:** uniprot · **Summarizer:** openai (`gpt-4o-mini`)

### Summary

Insulin-like growth factor 1 (IGF-1), also known as Insulin-like growth factor I or IGF-I, is a protein encoded by the IGF1 gene (UniProt Entry Name: IGF1_HUMAN, Accession: P05019). It plays a crucial role in growth promotion and metabolic regulation, being structurally related to insulin but with greater growth-promoting activity. IGF-1 stimulates glucose transport and glycogen synthesis in osteoblasts and is involved in various signaling pathways, including the PI3K-AKT and Ras-MAPK pathways. It acts as a ligand for the insulin-like growth factor 1 receptor (IGF1R), which mediates its effects on cell growth and survival. Variants in the IGF1 gene can lead to conditions such as insulin-like growth factor I deficiency.
